| CPC C12Q 1/6886 (2013.01) [G16B 20/20 (2019.02); C12Q 2600/154 (2013.01)] | 5 Claims |
|
1. A kit for predicting cervical cancer, comprising reagents and primers for DNA methylation measurements of CGIDs as set forth in SEQ ID NO:3, SEQ ID NO:31, and a combination thereof, wherein the reagents and primers are selected from:
a) a forward, biotinylated primer consisting of the nucleotide sequence SEQ ID NO:80, a reverse primer consisting of the nucleotide sequence SEQ ID NO:81, and a pyrosequencing primer consisting of the nucleotide sequence SEQ ID NO:82, for DNA methylation measurements of the CGIDs as set forth in SEQ ID NO: 31;
b) a forward primer consisting of the nucleotide sequence SEQ ID NO:90, and a reverse primer consisting of the nucleotide sequence SEQ ID NO:91, for DNA methylation measurements of the CGIDs as set forth in SEQ ID NO: 31;
c) a forward primer consisting of the nucleotide sequence SEQ ID NO:83, a reverse primer consisting of the nucleotide sequence SEQ ID NO:84, and a pyrosequencing primer consisting of the nucleotide sequence SEQ ID NO:85, for DNA methylation measurements of the CGIDs as set forth in SEQ ID NO: 3;
d) a forward primer consisting of the nucleotide sequence SEQ ID NO:88 and a reverse primer consisting of the nucleotide sequence SEQ ID NO:89, for DNA methylation measurements of the CGIDs as set forth in SEQ ID NO: 3; or
a combination of any one of a)-d).
|